Phytohemagglutinin-induced IL2 mRNA in whole blood can predict bortezomib-induced peripheral neuropathy for multiple myeloma patients

The proteasome inhibitor bortezomib has revolutionized the treatment of multiple myeloma. However, bortezomib-induced peripheral neuropathy (BiPN) is a serious complication that compromises clinical outcome. If patients with a risk of developing BiPN could be predicted, physicians might prefer weekl...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, T, Mitsuhashi, M, Sagawa, M, Ri, M, Suzuki, K, Abe, M, Ohmachi, K, Nakagawa, Y, Nakamura, S, Chosa, M, Iida, S, Kizaki, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816208/
https://www.ncbi.nlm.nih.gov/pubmed/24096714
http://dx.doi.org/10.1038/bcj.2013.47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816208/
https://www.ncbi.nlm.nih.gov/pubmed/24096714
http://dx.doi.org/10.1038/bcj.2013.47

Ejemplares similares